CardioSource WorldNews August 2013 | Page 13

Derek P, m.s. senior scientist molecular structure anD characterization

responding to a global threat.
Biotechnology vs cardiovascular Disease. the fight is on.
Every day, you’re on the front lines of cardiovascular disease. Now, the scientists at Amgen are battling right alongside you, bringing with them both the power of the biggest biotechnology company and the determination to persevere. Amgen therapeutics have helped many people around the world in the fight against serious illnesses. And if we have our way, cardiovascular disease will be no exception.
© 2013 Amgen Inc. All rights reserved. Not for Reproduction. 74747-R1-V2

Cardiovascular

CSWN_The_Beat_8'13.indd 11

8/19/13 5:00 PM